Skip to content
rapid black text
rapid black text
  • Home
  • About
    • Who We Are
    • Our Team
    • Join our Team
    • Partners
  • Products
    • 3D-RD-S
    • Pricing
    • Request Quote
    • FAQ
  • Services
  • News & Resources
    • News
    • Podcasts & Media
  • Home
  • About
    • Who We Are
    • Our Team
    • Join our Team
    • Partners
  • Products
    • 3D-RD-S
    • Pricing
    • Request Quote
    • FAQ
  • Services
  • News & Resources
    • News
    • Podcasts & Media
  • 3D-RD Log In
rapid black text
  • Home
  • About
    • Who We Are
    • Our Team
    • Join our Team
    • Partners
  • Products
    • 3D-RD-S
    • Pricing
    • Request Quote
    • FAQ
  • Services
  • News & Resources
    • News
    • Podcasts & Media
  • Home
  • About
    • Who We Are
    • Our Team
    • Join our Team
    • Partners
  • Products
    • 3D-RD-S
    • Pricing
    • Request Quote
    • FAQ
  • Services
  • News & Resources
    • News
    • Podcasts & Media
  • 3D-RD Log In

BE THE FIRST TO KNOW WHEN 3D-RD-S IS RELEASED

contact us

BE THE FIRST TO KNOW WHEN 3D-RD-S IS RELEASED

contact us

Rapid and University of Florida Awarded $1.65 Million NCI Grant to Enhance Dosimetry Software for Alpha-Emitter Radiopharmaceutical Therapy

  • Post author:web-designer
  • Post published:October 4, 2024
  • Post category:Uncategorized

Baltimore, Maryland, – Rapid®, in collaboration with Dr. Wesley Bolch and his group at the University of Florida, have been awarded a $1.65 million NCI Phase II SBIR grant to…

Continue ReadingRapid and University of Florida Awarded $1.65 Million NCI Grant to Enhance Dosimetry Software for Alpha-Emitter Radiopharmaceutical Therapy

Recent Posts

  • Rapid Awarded $2M NIH Grant to Develop Cloud-Based Quantitative SPECT Reconstruction Platform for Radiopharmaceutical Therapy
  • Rapid and University of Florida Awarded $1.65 Million NCI Grant to Enhance Dosimetry Software for Alpha-Emitter Radiopharmaceutical Therapy
  • Rapid’s, FDA-cleared dosimetry software, 3D-RD-S, Receives CE Mark Approval, Expanding Global Access to Cutting-Edge Radiopharmaceutical Dosimetry Software
  • Radiopharmaceutical Imaging and Dosimetry (Rapid®) receives FDA clearance for its first 3D-RD™ product: 3D-RD-S
  • Rapid receives a $2.0M NIH Phase II Grant, Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.

Recent Comments

    Archives

    • February 2025
    • October 2024
    • September 2023
    • February 2023
    • April 2021

    Categories

    • rapid dosimetry
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    About company

    Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) is a Baltimore-based company providing comprehensive expert service and software solutions related to quantitative imaging, dosimetry, in support of pre-clinical and clinical studies needed for regulatory approval and for the maximally effective and safe clinical implementation of radiopharmaceuticals.

    Customer
    • About Us
    • Latest News
    • Job Opportunities
    • Contact
    Information
    • Financial Conflict of Interest in PHS-Funded Projects Policy
    • Quality Policy
    • Cookies Policy
    • Terms of Use
    • Privacy Statement
    Subscribe to newsletter
    Follow Rapid Dosimetry
    Linkedin Facebook Twitter
    Join the Conversation
    Join the Conversation
    rapid black text

    Digital marketing by Weblify & Webtec

    3D-RD-S
    BE THE FIRST TO KNOW WHEN WE LAUNCH.
    Sign up now and gain early access to 3D-RD-S as well as a pre-launch discount code.
    We use cookies to ensure that we give you the best experience on our website. I agreeNoPrivacy policy